880 results on '"P. Dreger"'
Search Results
2. S282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISEASE, CANCER OR IMMUNOSUPPRESSION
3. P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION
4. P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA
5. P641: RETREATMENT WITH VENETOCLAX AFTER VENETOCLAX, OBINUTUZUMAB +/- IBRUTINIB: POOLED ANALYSIS OF 13 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED IN GCLLSG TRIALS
6. PB2270: CLEARANCE OF PERSISTENT SARS-COV2 INFECTION WITH ANTIBODY CONTAINING PLASMA IN LEUKEMIA AND LYMPHOMA PATIENTS
7. Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma
8. Unlocking Success: The Benefits of Utilizing the School Librarian Evaluation Instrument
9. Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study
10. Increased Expression of Inactive Rhomboid Protein 2 in Circulating Monocytes after Acute Myocardial Infarction
11. Factors affecting pretransplant muscle strength in allogeneic stem cell transplant candidates prior transplantation
12. Microbiological risk factors, ICU survival, and 1-year survival in hematological patients with pneumonia requiring invasive mechanical ventilation
13. Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)
14. How risky is a second allogeneic stem cell transplantation?
15. Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
16. Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
17. Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
18. The Conceptual Analysis of Disciplinary Evidence (CADE) Framework as a Guide for Evidentiary Reasoning: A Practical Implementation in a Hardy-Weinberg Equilibrium (HWE) Laboratory Investigation
19. Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye
20. Predictors of residual tricuspid regurgitation after interventional therapy: an automated deep-learning CT analysis
21. Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients
22. Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years
23. Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients
24. PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
25. Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0RİZE
26. The moderating effect of mental health and health insurance ownership on the relationships between physical multimorbidity and healthcare utilisation and catastrophic health expenditure in India
27. Situational XR: Are There More than Absolutes?
28. Reinforcement Practicality for Middle School Students: A Meta-Analysis
29. The Race to Leadership Effectiveness: A Study on School Organization for High and Low Performing Georgia Schools
30. Impact of smoking in patients with suspected coronary artery disease in the randomised DISCHARGE trial
31. Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison
32. Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma
33. Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
34. Medical graphics to improve patient understanding and anxiety in elderly and cognitively impaired patients scheduled for transcatheter aortic valve implantation (TAVI)
35. High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders
36. Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
37. Implementation of the ESC STEMI guidelines in female and elderly patients over a 20-year period in a large German registry
38. Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
39. Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis
40. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
41. Prehabilitative high-intensity interval training and resistance exercise in patients prior allogeneic stem cell transplantation
42. First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma
43. Utilization of innovative medical technologies in German inpatient care: does evidence matter?
44. Prevalence, one-year-incidence and predictors of carcinoid heart disease
45. Pilot study of an interprofessional pediatric mechanical ventilation educational initiative in two intensive care units
46. Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
47. Influence of lymph node degeneration on metastases in prostate cancer: or why we must look for a needle in a haystack
48. Hydrostatic pressure of the renal pelvis as a radiation-free alternative to fluoroscopic nephrostogram following percutaneous nephrolithotomy
49. Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study
50. Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.